iBio, Inc. IBIO
NASDAQ IBIO
$0.82 +0.04 (+5.67%)
At close: Nov 11, 2026 · 4:00 PM EST

iBio (IBIO) Gains (Losses) on Sale of Assets & Investments (2013 - 2024)

Updated

iBio (IBIO) reported Non Operating Investment Income of $1 million for FY2024 (year ended Jun 30, 2024).

Analysis

iBio (IBIO) Gains (Losses) on Sale of Assets & Investments (2013 - 2024) Analysis & Trends

  • The FY2024 figure ranks as the lowest annual Non Operating Investment Income since FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 iBio 118.23 Mn -174.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1.00 Mn
Jun 30, 2023 180,000.00
Mar 31, 2023 134,000.00
Dec 31, 2022 56,000.00
Jun 30, 2022 -149.87 Mn
Mar 31, 2022 -103,000.00
Dec 31, 2021 -27,000.00
Mar 31, 2014 3,000.00
Dec 31, 2013 -1,000.00
API Access

iBio Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IBIO&period=max&api_key=YOUR_API_KEY